In some cases the proportion of ALDH1+ cells has been reported to increase in breast cancer patients receiving neoadjuvant chemotherapy [6, 9]; in one study, those patients whose post-chemotherapy tumors showed an increase in ALDH1 + tumor cells had shorter disease-free survival than other patients [6]. Here, ALDH1A1 is linked to neoplasm.